Novel pharmacologic approaches to reduce bleeding

Can J Anaesth. 2003 Jun-Jul;50(6 Suppl):S26-30.

Author

Jerrold H Levy¹

Affiliation

¹ Department of Anesthesiology, Emory University School of Medicine, Division of Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, Georgia 30322, USA. jerrold_levy@emory.org

PMID: 14629050

No abstract available

Publication types

Review

MeSH terms

Anticoagulants / therapeutic use
Antifibrinolytic Agents / therapeutic use
Antithrombins / pharmacology
Antithrombins / therapeutic use
Aprotinin / therapeutic use
Deamino Arginine Vasopressin / therapeutic use
Hemorrhage / drug therapy*
Hemorrhage / prevention & control*
Heparin / therapeutic use
Heparin Antagonists / therapeutic use
Humans
Recombinant Proteins / therapeutic use

Substances

Anticoagulants
Antifibrinolytic Agents
Antithrombins
Heparin Antagonists
Recombinant Proteins
Heparin
Aprotinin
Deamino Arginine Vasopressin